April 10th, 2008 by Richard Brassaw
Lawsuits over drugs like Zyprexa, Vioxx, Rezulin have made headlines in the past decade. At the center of the lawsuits is if the pharmaceutical manufactures withheld research that indicated the drug had risk factors other than was presented to the Food and Drug Administration (FDA).
Currently there is a lawsuit over the birth control patch, Ortho [...]
April 9th, 2008 by Richard Brassaw
For some time the Holy Grail of Alzheimer’s disease was thought to be a medication to clear beta-amyloid plaques from the brain, but current research suggest that isn’t going to be enough.
An study by the University of California, Irvine, has been testing an Alzheimer’s drug designed to clear the beta-amyloid plaques. Unfortunately, clearing the plaques [...]
April 8th, 2008 by Richard Brassaw
Studies have shown that high levels of cholesterol break down the blood-brain barrier (BBB), reducing it effectiveness against damage by blood borne contamination to the central nervous system (CNS).
Researchers from the University of North Dakota School of Medicine and Health Sciences gave rabbits 3 mg of caffeine each day–equivalent to a daily cup of coffee [...]
April 7th, 2008 by Richard Brassaw
A recent study found that Parkinson’s disease patients typically have low-density lipoprotein (LDL) levels. What researchers could not establish was if the low LDL levels were the result of Parkinson’s or a possible precursor to the disease.
Dr. Xuemei Huang, medical director of Movement Disorder Clinic, University of North Carolina, Chapel Hill, NC, believes he has [...]
April 6th, 2008 by Richard Brassaw
Scientist have known that genes associated with type 2 diabetes are involved with other diseases, like heart disease and prostrate cancer. There are about 25,000 genes, but so far the same genomic regions keep coming up in studies of different diseases.
Laura Scott, assistant research scientist, Department of Biostatistics, University of Michigan, along with European researchers, [...]
April 5th, 2008 by Richard Brassaw
Approximately 75% of patients with diabetes die from cardiovascular disease. Determining the optimal treatment for diabetes patients with coronary artery disease is the subject of a recent JAMA article.
Steven E. Nissen, MD, Cleveland Clinic, and colleagues, compared the effectiveness of two alternative approaches for treating hyperglycemia, an insulin-providing strategy (glimepiride) versus an insulin-sensitizing strategy (pioglitazone), [...]
April 4th, 2008 by Richard Brassaw
Health practitioners have been warning patients the ‘lower the better’ for cholesterol and blood pressure in order to reduce the risk of a heart attack. Now there is evidence that patients with either type 1 or type 2 diabetes practitioners should add ‘the sooner, the better’ for prevention of cardiovascular disease.
Tina Ken Schramm, MD, Gentofte [...]
April 3rd, 2008 by Richard Brassaw
In 1993 researchers identified “superoxide dismutase” as the cause for sporadic amyotrophic lateral sclerosis (ALS). ALS is often referred to as Lou Gehrig’s disease and affects motor neurons that leads to paralysis and death within 1-5 years.
Doctors Guy Rouleau, Edor Kabashi, Paul Valdmanis, all of Research Centre of the Centre hospitalier de l’Université de Montréal (CRCHUM), [...]
April 2nd, 2008 by Richard Brassaw
Insomnia is the most commonly reported sleep disorder. Approximately, 30% of adults have insomniac symptoms. Traditional thinking suggested that insomnia is the result of depression.
Jules Angst, MD, Zurich University Psychiatric Hospital, Switzerland, conducted 6 interviews with 591 young adults over a 20 year period. He was able to distinguish 4 subtypes of insomnia:
One-month insomnia (associated [...]
April 1st, 2008 by Richard Brassaw
Type 2 Diabetes has been known to respond well to a vegetable that is used in traditional Chinese medicine–bitter melon. Bitter melon is bitter in taste, non-toxic, and thought to expel evil heat and relieve fatigue…according to the famous Compendium of Materia Medican, by Li Shizhen (1518-1593).
Researchers from the Shanghai Institute of Materia Medica wanted [...]